Literature DB >> 7332732

Ethanol 'dose-dependent' elimination: Michaelis-Menten v classical kinetic analysis.

R E Rangno, J H Kreeft, D S Sitar.   

Abstract

1 To compare classical linear regression techniques and a Michaelis-Menten elimination model eight normal human volunteers each received three intravenous doses (0.375, 0.5, and 0.75 g/kg) of ethanol and four of the subjects each received four oral doses (0.5, 0.65, 0.95, 1.25 g/kg) of ethanol. 2 Computerized analysis of the time-plasma concentration profiles using a two-compartment Michaelis-Menton elimination model yielded a median absorption constant of 1.29 h-1; volume of distribution of 0.47 l/kg; Vmax of 0.12 g h-1 kg-1; and Km of 0.03 g/l. Classical techniques resulted in a slope of 0.20 g l-1 h-1, volume of distribution of 0.55 l/kg, and a B60 of 0.11 g h-1 kg-1. 3 Transient post-prandial decreases in elimination slope occurred at higher oral doses. A trend of increasing slope with increasing oral dose was seen at concentrations well above the Km. Time to sobriety (0.8 g/l) increased nonlinearly with increasing peak concentration. 4 Maximal ethanol elimination rates are determined equally well by the two techniques. Classical analyses overestimate the volume of distribution of ethanol by 17%. Neither technique helps explain the post-prandial changes in slope or increasing slope with dose at high concentrations.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7332732      PMCID: PMC1401959          DOI: 10.1111/j.1365-2125.1981.tb01287.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  12 in total

1.  Effects of solid food on blood levels of alcohol in man.

Authors:  Y Lin; D J Weidler; D C Garg; J G Wagner
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1976-04

2.  Elimination of alcohol from human blood.

Authors:  J G Wagner; P K Wilkinson; A J Sedman; D R Kay; D J Weidler
Journal:  J Pharm Sci       Date:  1976-01       Impact factor: 3.534

3.  Blood flow limitations in interpreting Michaelis constants for ethanol oxidation in vivo.

Authors:  R L Dedrick; D D Forrester
Journal:  Biochem Pharmacol       Date:  1973-05-15       Impact factor: 5.858

4.  Properties of the Michaelis-Menten equation and its integrated form which are useful in pharmacokinetics.

Authors:  J G Wagner
Journal:  J Pharmacokinet Biopharm       Date:  1973-04

5.  Genetic and environmental factors affecting ethanol metabolism in man.

Authors:  E S Vesell; J G Page; G T Passananti
Journal:  Clin Pharmacol Ther       Date:  1971 Mar-Apr       Impact factor: 6.875

6.  Distribution of ethanol between plasma and erythrocytes in whole blood.

Authors:  J P Payne; D W Hill; D G Wood
Journal:  Nature       Date:  1968-03-09       Impact factor: 49.962

7.  The kinetics of ethanol absorption and elimination in twins and supplementary repetitive experiments in singleton subjects.

Authors:  M Kopun; P Propping
Journal:  Eur J Clin Pharmacol       Date:  1977       Impact factor: 2.953

8.  Fasting and nonfasting blood ethanol concentrations following repeated oral administration of ethanol to one adult male subject.

Authors:  P K Wilkinson; A J Sedman; E Sakmar; Y J Lin; J G Wagner
Journal:  J Pharmacokinet Biopharm       Date:  1977-02

9.  Blood ethanol concentrations during and following constant-rate intravenous infusion of alcohol.

Authors:  P K Wilkinson; A J Sedman; E Sakmar; R H Earhart; D J Weidler; J G Wagner
Journal:  Clin Pharmacol Ther       Date:  1976-02       Impact factor: 6.875

10.  Aging and ethanol metabolism.

Authors:  R E Vestal; E A McGuire; J D Tobin; R Andres; A H Norris; E Mezey
Journal:  Clin Pharmacol Ther       Date:  1977-03       Impact factor: 6.875

View more
  16 in total

1.  Within- and between-subject variations in pharmacokinetic parameters of ethanol by analysis of breath, venous blood and urine.

Authors:  A Norberg; J Gabrielsson; A W Jones; R G Hahn
Journal:  Br J Clin Pharmacol       Date:  2000-05       Impact factor: 4.335

2.  Backtracking booze with Bayes--the retrospective interpretation of blood alcohol data.

Authors:  P R Jackson; G T Tucker; H F Woods
Journal:  Br J Clin Pharmacol       Date:  1991-01       Impact factor: 4.335

3.  Does the benzodiazepine antagonist Ro 15-1788 antagonize the action of ethanol?

Authors:  U Klotz; G Ziegler; B Rosenkranz; G Mikus
Journal:  Br J Clin Pharmacol       Date:  1986-11       Impact factor: 4.335

Review 4.  Role of variability in explaining ethanol pharmacokinetics: research and forensic applications.

Authors:  Ake Norberg; A Wayne Jones; Robert G Hahn; Johan L Gabrielsson
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

Review 5.  Pharmacokinetic and pharmacodynamic principles of illicit drug use and treatment of illicit drug users.

Authors:  D I Quinn; A Wodak; R O Day
Journal:  Clin Pharmacokinet       Date:  1997-11       Impact factor: 6.447

6.  Effect of omeprazole on gastric first-pass metabolism of ethanol.

Authors:  R Roine; R Hernández-Muñoz; E Baraona; R Greenstein; C S Lieber
Journal:  Dig Dis Sci       Date:  1992-06       Impact factor: 3.199

7.  Non-linear kinetics of 4-methylpyrazole in healthy human subjects.

Authors:  D Jacobsen; S K Barron; C S Sebastian; R Blomstrand; K E McMartin
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

8.  First-pass metabolism of alcohol. Absence of diurnal variation and its inhibition by cimetidine after evening meal.

Authors:  R Sharma; R T Gentry; R T Lim; C S Lieber
Journal:  Dig Dis Sci       Date:  1995-10       Impact factor: 3.199

9.  Influence of dose range on degree of nonlinearity detected in dose-proportionality studies for drugs with saturable elimination: single-dose and steady-state studies.

Authors:  T A Shepard; N Lordi; P E Sparrow
Journal:  Pharm Res       Date:  1993-02       Impact factor: 4.200

10.  Alcohol and bupropion pharmacokinetics in healthy male volunteers.

Authors:  J Posner; A Bye; S Jeal; A W Peck; P Whiteman
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.